Navarro Discount Pharmacy celebrates opening of 30th store
MIAMI — Navarro Discount Pharmacy, a Hispanic-owned pharmacy chain and an MBF Healthcare portfolio company, has opened its 30th store in Homestead in the Homestead Pavilion Shopping Center.
For added convenience and improved customer service, the pharmacy department has been moved to the front of the new 11,280-sq.-ft. store. The store layout features new colors and enhanced signage in English and Spanish, wider aisles, a larger fragrance section with added light boxes, and more products in the refrigerated food and dairy section. Services for customers include a pediatric window for busy parents, compounding pharmacy services, a free Diabetes Club for adults and children with diabetes, and free prescription delivery for all customers.
Navarro’s shelves in Homestead are stocked with ethnic products for the Mexican community, including Jumex nectars, an extensive variety of chili peppers, piñatas and Hispanic products from Goya and Gamesa. Signature products for Hispanics also available in the Homestead store include Café La Llave Expresso coffee and Fabuloso multipurpose cleaner, plus such popular brands as Valentini, El Sembrador and La Fe. Navarro’s new Vida Mia private-label brand products, with labels in English and Spanish, also are available in the store.
“Due to the strength of the Navarro brand in the Hispanic community, the new Homestead store, our southernmost store, has had excellent traffic and higher than normal opening sales,” stated Juan Ortiz, CEO of Navarro Discount Pharmacy. “There is a tremendous need locally for a community pharmacy such as Navarro and a lot of pent up demand.” As part of Navarro’s 22-store expansion strategy, the next store opening after Homestead is Pembroke Pines in Broward County in the spring of 2012.
Attending the ribbon-cutting ceremony and grand opening were Homestead mayor Steven Bateman, vice mayor Jon Burgess and Greater Homestead/Florida City Chamber of Commerce chairman Linda Hicks. The first 200 customers received a free Navarro reusable bag filled with product, there was free product sampling throughout the day and special 2-for-1 product offers. Representatives from Florida Health College, Dade Medical College and the American Heart Association staffed tables and administered free vascular, glucose and vitals screenings for customers.
Pfizer completes Excaliard acquisition
NEW YORK — Pfizer completed its acquisition of a drug maker that focuses on the development of skin scarring treatments.
Pfizer said its acquisition of Excaliard Pharmaceuticals will allow the company to develop "new and innovative treatments to address unmet medical needs," noting that there currently is no excessive skin scarring treatment approved by the Food and Drug Administration.
Financial terms of the deal, which was announced last month, were not disclosed; however, Pfizer said it provided Excaliard’s shareholders — which include Isis Pharmaceuticals, Alta Partners, ProQuest Investments and RiverVest Venture Partners — an upfront payment and will make contingent payments if certain milestones are achieved in the future.
Mylan generic drug for HIV/AIDS receives tentative FDA approval through PEPFAR
PITTSBURGH — Under the President’s Emergency Plan for AIDS Relief, the Food and Drug Administration has given tentative approval to a generic HIV and AIDS drug made by Mylan, the company said.
The drug maker’s Mylan Labs subsidiary received tentative approval for atazanavir sulfate and ritonavir tablets in the 300-mg/100-mg strength. The FDA’s tentative approval of the drug under PEPFAR means it will be eligible for purchase in certain developing countries.
Mylan said the drug was the first heat-stable, fixed-dose combination of the two drugs. The World Health Organization also "pre-qualified" the drug as a second-line treatment option for HIV and AIDS, the company said.
Atazanavir sulfate is a generic version of Bristol-Myers Squibb’s Reyataz, while ritonavir is a generic version of Abbott Labs’ Norvir.